SCHEMBL18655356

SCHEMBL18655356

CNc1c2ccccc2nc2c1cnc1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.47
KDM1A O60341 5/20 0.46
TLR7 Q9NYK1 2/20 0.43
KDM4E B2RXH2 3/20 0.43
GPR3 P46089 1/20 0.43
ATM Q13315 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
NUDT1 P36639 1/20 0.39
LMNA P02545 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ELANE P08246 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18655366 0.86 HDAC3 (0.40) LRRK2KDM1ATLR7KDM4EADORA3
SCHEMBL18655361 0.86 MAPT (0.39) LRRK2KDM1ATLR7KDM4EGPR3
SCHEMBL18655368 0.82 POLB (0.48) KDM4ELMNAMEN1ALDH1A1GLA
SCHEMBL5410460 0.80 KDM1A (0.66) KDM1AKDM4EATMADORA3NUDT1
SCHEMBL18655365 0.78 MAOA (0.50) KDM1AKDM4EATMNUDT1LMNA
Iodide SCHEMBL17187186 0.78 KDM1A (0.63) KDM1AKDM4EATMADORA3NUDT1
SCHEMBL18650758 0.74 ACHE (0.61) TLR7KDM4EGPR3ADORA3LMNA
SCHEMBL9212223 0.74 LRRK2 (0.46) LRRK2KDM1AKDM4EGPR3ATM
SCHEMBL13652174 0.74 ERN1 (0.50) LRRK2KDM1AKDM4EGPR3ATM
SCHEMBL18650740 0.74 MAOA (0.61) TLR7KDM4EGPR3ADORA3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170081351-A1 Design, Synthesis, and Biological Activity of Platinum-benz[c]acridine Hybrid Agents and Methods Associated Therewith WAKE FOREST UNIVERSITY 2017-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081351-A1 Design, Synthesis, and Biological Activity of Platinum-benz[c]acridine Hybrid Agents and Methods Associated Therewith ACR, TP53, MCL1 LRRK2 1199/4885KDM1A 3582/4885TLR7 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.